title: Selective decontamination of the digestive tract and fungal infection in acute leukemia patients.
abstract: For prevention of infection we used an SD design including antibacterial (trimethoprim 480 mg/daily, sulfamerazine 720 mg/daily, and polymyxin 0.25 mg/daily) and antifungal (4-6 million IU nystatin/daily) components. We analyzed retrospectively 138 treatment periods in 108 patients. The intensified chemotherapy resulted in severe granulocytopenia below 0.1 x 10(9)/liter over 25.2 days. In 19 patients there was suspicion of major fungal infection; therefore they were given amphotericin B and 5-fluocytosine. Fourteen of them died; major fungal infections were documented in 5 cases. In 18% of all the deceased we found major fungal infections. There was a correlation between fungal infection, the late stages of the hematological malignancy, and the lesions on the oropharyngeal mucosa. However, in terms of the serological and culture findings no correlation appeared to exist between the group with and the group without fungal infection. The SD regime is meant to suppress the Candida cell concentration in the digestive tract but has no influence on Aspergillus in the respiratory tract.
authors.affiliation: Abteilung für Hämatologie, Wilhelm-Pieck-Universität, Rostock, GDR.
authors.forename: I
authors.initials: I
authors.lastname: Günther
authors.forename: U
authors.initials: U
authors.lastname: Kaben
authors.forename: H
authors.initials: H
authors.lastname: Dunker
authors.forename: R
authors.initials: R
authors.lastname: Brijmohan-Günther
authors.forename: H
authors.initials: H
authors.lastname: Konrad
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000517:prevention & control*; D004064:Digestive System / Q000382:microbiology*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000517:prevention & control*; D009761:Nystatin / Q000008:administration & dosage*; D009894:Opportunistic Infections / Q000517:prevention & control*; D011113:Polymyxins / Q000008:administration & dosage; D013416:Sulfamerazine / Q000008:administration & dosage; D014295:Trimethoprim / Q000008:administration & dosage
chemical_list: D011113:Polymyxins; D009761:Nystatin; D014295:Trimethoprim; D013416:Sulfamerazine